Electronic Cigarettes for Nicotine Addiction

Phase-Based Progress Estimates
Nicotine Addiction+1 MoreElectronic Cigarette - Drug
21 - 65
All Sexes
What conditions do you have?

Study Summary

This trial will test whether electronic cigarettes help methadone-maintained smokers quit smoking.

Eligible Conditions
  • Nicotine Addiction
  • Vaping

Treatment Effectiveness

Effectiveness Progress

3 of 3
This is further along than 93% of similar trials

Study Objectives

10 Primary · 0 Secondary · Reporting Duration: 6 weeks

6 weeks
FEV1 Lung Functioning
FEV1 Lung Functioning for Complete Switchers
FEV1/FVC Ratio Lung Functioning
FEV1/FVC Ratio Lung Functioning for Complete Switchers
FVC Lung Functioning
FVC Lung Functioning for Complete Switchers
Nicotine Exposure
Nicotine Exposure for Complete Switchers
Smoking Behavior and Experiences
Smoking Behavior and Experiences for Complete Switchers

Trial Safety

Safety Progress

3 of 3
This is further along than 85% of similar trials

Trial Design

2 Treatment Groups

Electronic Cigarettes
1 of 2
Nicotine Lozenges
1 of 2

Active Control

240 Total Participants · 2 Treatment Groups

Primary Treatment: Electronic Cigarettes · No Placebo Group · Phase 4

Electronic Cigarettes
ActiveComparator Group · 1 Intervention: Electronic Cigarette · Intervention Types: Drug
Nicotine Lozenges
ActiveComparator Group · 1 Intervention: Nicotine Lozenge · Intervention Types: Drug

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 6 weeks

Who is running the clinical trial?

National Institute on Drug Abuse (NIDA)NIH
2,248 Previous Clinical Trials
2,028,841 Total Patients Enrolled
12 Trials studying Nicotine Addiction
2,001 Patients Enrolled for Nicotine Addiction
Butler HospitalLead Sponsor
123 Previous Clinical Trials
16,358 Total Patients Enrolled

Eligibility Criteria

Age 21 - 65 · All Participants · 7 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You are a moderate to heavy smoker.
You must be able to speak English.